Hybrid PET/MRI spares 20% of brain tumor patients from unnecessary follow-up treatment

Aug 15, 2021 Radiology Updates

A molecular, hybrid imaging approach accurately detects malignant brain tumors while also preventing unnecessary invasive procedures, recently published research suggests.

Combined PET/MRI scanning with radiopharmaceuticals such as 18F-fluorethyl tyrosine (18F-FET) has proven to enhance diagnostic performance, but there’s less evidence such imaging impacts clinical decision-making. German researchers tested the approach in patients with brain tumors, reporting positive results.

Further studies considering these aspects might evaluate finally if 18F-FET PET/MR as a hybrid modality qualifies for evidence-based use in clinical routine.

Read the full article: https://www.healthimaging.com/topics/molecular/petmri-brain-tumor-patients-unnecessary-treatment

Leave a Reply

Your email address will not be published. Required fields are marked *